CLEAR CELL SARCOMA (CCS)
Clinical trials for CLEAR CELL SARCOMA (CCS) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL SARCOMA (CCS) trials appear
Sign up with your email to follow new studies for CLEAR CELL SARCOMA (CCS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on rare sarcoma in early trial
Disease control Recruiting nowThis study tests a drug called vebreltinib for people with advanced clear cell sarcoma, a rare cancer of soft tissues. About 30 participants will take the pill twice a day to see if it can shrink tumors or stop the cancer from growing. The study also compares their results to a g…
Matched conditions: CLEAR CELL SARCOMA (CCS)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for rare sarcoma: tebentafusp trial launches
Disease control Recruiting nowThis study tests a drug called tebentafusp in people with a rare cancer called clear cell sarcoma that has spread or cannot be removed by surgery. Only patients with a specific genetic marker (HLA-A*02:01) can join. The main goal is to see if the drug can keep the cancer from gro…
Matched conditions: CLEAR CELL SARCOMA (CCS)
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 11, 2026 20:49 UTC